Tag: Precision medicine
Revolutionary CRISPR Treatment Corrects Genetic Misspelling in Landmark Case
For the first time, scientists said they reached into the genome of a really sick kid and changed the unique misspelling in his DNA....
David Epstein launches new cancer startup after Novartis and Seagen career
David Epstein, who previously served as the CEO of Seagen, has launched a new cancer startup called Ottimo Pharma. The company aims to develop...
Exploring R&D Strategies of Amgen, Biogen, and Takeda for Challenging Targets
Amgen, Biogen, and Takeda are three biopharma companies facing challenges in developing treatments for obesity and Alzheimer's disease. At the STAT 2024 Summit in...